BioCentury
ARTICLE | Clinical News

Bayer preclinical data

July 13, 2015 7:00 AM UTC

In a mouse model of hemophilia A, single doses of 0.6-2 mg/kg IV BAY 1093884 given prior to induced bleeding led to a 50% survival rate for up to 6 days vs. a 25% survival rate for 1,000 IU/kg of reco...